-+ 0.00%
-+ 0.00%
-+ 0.00%

Reported Sunday, UroGen Presents New Data Showing UGN-102 Does Not Adversely Affect Functionality or Symptom Burden

Benzinga·04/28/2025 05:41:22
Listen to the news
  • New analysis of patient-reported outcomes from the OPTIMA II, ATLAS and ENVISION studies of UGN-102 presented at the American Urological Association (AUA) 2025 Annual Meeting in Las Vegas, Nevada